uniQure N.V (QURE) is 29.10% away from 50-day simple Moving Average despite all headwinds

uniQure N.V (NASDAQ: QURE) kicked off on Monday, up 7.58% from the previous trading day, before settling in for the closing price of $14.77. Over the past 52 weeks, QURE has traded in a range of $3.73-$19.18.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company grew by 323.68% over the past five years. While this was happening, its average annual earnings per share was recorded 20.69%. With a float of $50.09 million, this company’s outstanding shares have now reached $54.73 million.

Let’s look at the performance matrix of the company that is accounted for 209 employees. In terms of profitability, gross margin is 12.88%, operating margin of -696.25%, and the pretax margin is -874.39%.

uniQure N.V (QURE) Insider and Institutional Ownership

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of uniQure N.V is 8.47%, while institutional ownership is 75.54%. The most recent insider transaction that took place on Mar 04 ’25, was worth 291,629. In this transaction CEO, Managing Director of this company sold 28,341 shares at a rate of $10.29, taking the stock ownership to the 651,454 shares. Before that another transaction happened on Mar 04 ’25, when Company’s Chief Medical Officer sold 1,350 for $10.29, making the entire transaction worth $13,891. This insider now owns 151,903 shares in total.

uniQure N.V (QURE) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around 20.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.41% during the next five years compared to -9.66% drop over the previous five years of trading.

uniQure N.V (NASDAQ: QURE) Trading Performance Indicators

Take a look at uniQure N.V’s (QURE) current performance indicators. Last quarter, stock had a quick ratio of 9.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 32.07.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.92, a number that is poised to hit -1.00 in the next quarter and is forecasted to reach -3.33 in one year’s time.

Technical Analysis of uniQure N.V (QURE)

uniQure N.V (NASDAQ: QURE) saw its 5-day average volume 1.24 million, a negative change from its year-to-date volume of 1.35 million. As of the previous 9 days, the stock’s Stochastic %D was 82.60%. Additionally, its Average True Range was 1.17.

During the past 100 days, uniQure N.V’s (QURE) raw stochastic average was set at 72.94%, which indicates a significant decrease from 95.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 134.93% in the past 14 days, which was lower than the 154.71% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $12.31, while its 200-day Moving Average is $10.06. Nevertheless, the first resistance level for the watch stands at $16.39 in the near term. At $16.90, the stock is likely to face the second major resistance level. The third major resistance level sits at $17.59. If the price goes on to break the first support level at $15.19, it is likely to go to the next support level at $14.50. The third support level lies at $13.99 if the price breaches the second support level.

uniQure N.V (NASDAQ: QURE) Key Stats

The company with the Market Capitalisation of 869.64 million has total of 54,776K Shares Outstanding. Its annual sales at the moment are 27,120 K in contrast with the sum of -239,560 K annual income. Company’s last quarter sales were recorded 5,220 K and last quarter income was -73,260 K.